Nucleophagy identified as key DNA repair mechanism in cancer treatments

A team of international researchers at the University of Oxford (Oxford) and Nanyang Technological University, Singapore (NTU Singapore), has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments.

AHA 2024: Phase III BROOKLYN trial – safety and efficacy of obicetrapib in HeFH patients – Pharmaceutical Technology

On 18 November, at the American Heart Association (AHA) 2024 Annual Scientific Sessions in Chicago, Illinois, US, during a late-breaking session on the topic of

November 20, 2024

Digital health funding flattens out, PitchBook report shows

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 27, 2024

Tips for parents to safeguard children from online gaming risks

As online gaming becomes an increasingly popular pastime among children, parents continue to grow concerned about the potential risks and dangers their children may be

August 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.